Literature DB >> 11449366

Association of SLP-65/BLNK with the B cell antigen receptor through a non-ITAM tyrosine of Ig-alpha.

N Engels1, B Wollscheid, J Wienands.   

Abstract

The cytoplasmic adaptor protein SLP-65 (BLNK or BASH) is a critical downstream effector of the B cell antigen receptor (BCR). Tyrosine-phosphorylated SLP-65 assembles intracellular signaling complexes such as the Ca(2 +) initiation complex encompassing phospholipase C-gamma2 and Bruton's tyrosine kinase. It is, however, unclear how the SLP-65 signaling module can be recruited to the plasma membrane. Here we show that following B cell stimulation, SLP-65 associates directly with the BCR signaling subunit, the Ig-alpha / Ig-beta heterodimer. The interaction is mediated by the Src homology 2 domain of SLP-65 and the phosphorylated Ig-alpha tyrosine 204, which is located outside of the immunoreceptor tyrosine-based activation motif. Our data identify an unexpected BCR phosphorylation pattern and indicate that Ig-alpha has the capability to serve as transmembrane adaptor in BCR signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11449366     DOI: 10.1002/1521-4141(200107)31:7<2126::aid-immu2126>3.0.co;2-o

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

Review 1.  ITAMs versus ITIMs: striking a balance during cell regulation.

Authors:  Daniel D Billadeau; Paul J Leibson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  Adapters in lymphocyte signaling.

Authors:  Albrecht Leo; Jürgen Wienands; Gottfried Baier; Vaclav Horejsi; Burkhart Schraven
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 3.  The B-cell receptor signaling pathway as a therapeutic target in CLL.

Authors:  Jennifer A Woyach; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

Review 4.  Ligand-independent signaling during early avian B cell development.

Authors:  Kelly A Pike; Michael J H Ratcliffe
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  BLNK binds active H-Ras to promote B cell receptor-mediated capping and ERK activation.

Authors:  Yasuhiro Imamura; Akihisa Oda; Takashi Katahira; Kenji Bundo; Kelly A Pike; Michael J H Ratcliffe; Daisuke Kitamura
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

6.  SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins.

Authors:  Thomas Oellerich; Mads Grønborg; Konstantin Neumann; He-Hsuan Hsiao; Henning Urlaub; Jürgen Wienands
Journal:  Mol Cell Proteomics       Date:  2009-04-16       Impact factor: 5.911

7.  Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells.

Authors:  Niklas Engels; Lars Morten König; Christina Heemann; Johannes Lutz; Takeshi Tsubata; Sebastian Griep; Verena Schrader; Jürgen Wienands
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

8.  SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling.

Authors:  Peter Draber; Ivana Vonkova; Ondrej Stepanek; Matous Hrdinka; Marketa Kucova; Tereza Skopcova; Pavel Otahal; Pavla Angelisova; Vaclav Horejsi; Mandy Yeung; Arthur Weiss; Tomas Brdicka
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

9.  The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways.

Authors:  Shara Kabak; Brian J Skaggs; Michael R Gold; Michael Affolter; Kelly L West; Mark S Foster; Karyn Siemasko; Andrew C Chan; Ruedi Aebersold; Marcus R Clark
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

10.  The Dok-3/Grb2 protein signal module attenuates Lyn kinase-dependent activation of Syk kinase in B cell antigen receptor microclusters.

Authors:  Marion Lösing; Ingo Goldbeck; Birgit Manno; Thomas Oellerich; Tim Schnyder; Hanibal Bohnenberger; Björn Stork; Henning Urlaub; Facundo D Batista; Jürgen Wienands; Michael Engelke
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.